Connect your thoughts.Connect your thoughts.Connect with the world.Connect with the world.Connect to health.Connect to health.
Our Business
As a team of pharmaceutical specialists, we support your business from drug discovery to manufacturing.
More
SPI’s Strength
Leveraging the global network and pharmaceutical expertise, we provide consistent support from drug discovery to manufacturing. Having our own labs is also one of our strengths.
More
About Us
As a core company in the Sumitomo Corporation Group, we contribute to enriching lives and the world through the improvement of health and well-being by linking pharmaceutical-related companies in Japan and overseas.
More
Our
Business
As a team of pharmaceutical specialists, we support your business from drug discovery to manufacturing.
SPI’s StrengthLeveraging the global network and pharmaceutical expertise, we provide consistent support from drug discovery to manufacturing.
Having our own labs is also one of our strengths.
Leveraging the global network and pharmaceutical expertise, we provide consistent support from drug discovery to manufacturing. Having our own labs is also one of our strengths.
About UsAs a core company in the Sumitomo Corporation Group, we contribute to enriching lives and the world through the improvement of health and well-being by linking pharmaceutical-related companies in Japan and overseas.
As a core company in the Sumitomo Corporation Group, we contribute to enriching lives and the world through the improvement of health and well-being by linking pharmaceutical-related companies in Japan and overseas.
Notifications
News Release
2025.04.28
Summit Pharmaceuticals International Corporation Celebrates 40th Anniversary as ATCC’s distributor in Japan
Events/Exhibitions
2024.12.25
We will set up a booth at CPHI Japan 2025
News Release
2024.12.17
Luxna and SPI Announce License Agreement for manufacturing and sales of Luxna’s xeno modified nucleic acid amidite
News Release
2024.11.06
Inocras and Summit Pharmaceuticals International Corporation Announce Collaboration aim to Transform Clinical Genomics in Japan
News Release
2024.10.15
Summit Pharmaceuticals International Corporation Invests in EVerMed Inc.
Related Websites
Bioresource Materials
We are an officail distributor in Japan for Addgene, a nonprofit plasmid bank, as well as ATCC, the world’s largest biological resource bank.
Bio Research Instruments and Reagents
We sell cutting-edge research instruments and reagents.
Drug discovery partnering support
We identify, introduce, and mediate startups with unique drug discovery services in Japan and overseas. Through CDMO, we also handle manufacturing services for bio products.
CONTACT
(10:00 to 17:00, weekdays only)